These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11217356)
1. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356 [No Abstract] [Full Text] [Related]
2. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Liebich HM; Xu G; Di Stefano C; Lehmann R J Chromatogr A; 1998 Jan; 793(2):341-7. PubMed ID: 9474787 [TBL] [Abstract][Full Text] [Related]
3. Application of capillary electrophoresis in clinical chemistry: the clinical value of urinary modified nucleosides. Liebich HM; Lehmann R; Xu G; Wahl HG; Häring HU J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(1):189-96. PubMed ID: 10997714 [TBL] [Abstract][Full Text] [Related]
4. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers. Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203 [TBL] [Abstract][Full Text] [Related]
5. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography. Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266 [TBL] [Abstract][Full Text] [Related]
6. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264 [TBL] [Abstract][Full Text] [Related]
7. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry. Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199 [TBL] [Abstract][Full Text] [Related]
8. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography]. Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995 [TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341 [TBL] [Abstract][Full Text] [Related]
10. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors. Zhao R; Xu G; Yue B; Liebich HM; Zhang Y J Chromatogr A; 1998 Dec; 828(1-2):489-96. PubMed ID: 9916327 [TBL] [Abstract][Full Text] [Related]
11. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer. Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction. Szymańska E; Markuszewski MJ; Bodzioch K; Kaliszan R J Pharm Biomed Anal; 2007 Sep; 44(5):1118-26. PubMed ID: 17590562 [TBL] [Abstract][Full Text] [Related]
13. Urinary modified nucleosides as tumor markers. Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327 [TBL] [Abstract][Full Text] [Related]
14. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients. Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352 [TBL] [Abstract][Full Text] [Related]
15. Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion. Marvel CC; Del Rowe J; Bremer EG; Moskal JR Mol Chem Neuropathol; 1994; 21(2-3):353-68. PubMed ID: 7522008 [TBL] [Abstract][Full Text] [Related]
16. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides. Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869 [TBL] [Abstract][Full Text] [Related]
17. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE. Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143 [TBL] [Abstract][Full Text] [Related]
18. [Development of high performance liquid chromatographic method using monolithic column for the determination of urinary nucleosides]. Zhao X; Zheng Y; Zhang P; Kong H; Xu G Se Pu; 2005 Jan; 23(1):73-5. PubMed ID: 15881371 [TBL] [Abstract][Full Text] [Related]
19. A noninvasive cancer detection strategy based on gold nanoparticle surface-enhanced raman spectroscopy of urinary modified nucleosides isolated by affinity chromatography. Feng S; Zheng Z; Xu Y; Lin J; Chen G; Weng C; Lin D; Qiu S; Cheng M; Huang Z; Wang L; Chen R; Xie S; Zeng H Biosens Bioelectron; 2017 May; 91():616-622. PubMed ID: 28103517 [TBL] [Abstract][Full Text] [Related]
20. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations. Seidel A; Seidel P; Manuwald O; Herbarth O Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]